(Q43698456)

26 November 2017

title

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up (English)

1 reference

26 November 2017

1 reference

Gibbie T

1

1 reference

26 November 2017

Mijch A

2

1 reference

26 November 2017

Ellen S

3

1 reference

26 November 2017

Hoy J

4

1 reference

26 November 2017

Hutchison C

5

1 reference

26 November 2017

Wright E

6

1 reference

26 November 2017

Chua P

7

1 reference

26 November 2017

Judd F

8

1 reference

26 November 2017

language of work or name

1 reference

1 March 2006

1 reference

26 November 2017

1 reference

26 November 2017

volume

7

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

112-121

1 reference

The AIDS dementia complex: I. Clinical features

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Determinants of depression and HIV-related worry among HIV-positive women who have recently given birth, Bangkok, Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Anxiety and depression among HIV-infected heterosexuals--a report from India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

The prevalence of distress in persons with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Secondary mania in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Influence of depressed mood on neuropsychologic performance in HIV‐seropositive drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Assessing persons with human immunodeficiency virus (HIV) infection using the Beck Depression Inventory: disease processes and other potential confounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00350.X

10.1111/J.1468-1293.2006.00350.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference